世界の血行動態モニタリング装置市場:心拍出量モニタリング装置、肺動脈カテーテル

◆英語タイトル:Hemodynamic Monitoring Devices - Global Trends, Estimates and Forecasts, 2012-2018
◆商品コード:AXIS41204
◆発行会社(リサーチ会社):Axis Research Mind
◆発行日:2014年11月
◆ページ数:504
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User LicenseUSD3,250 ⇒換算¥338,000見積依頼/購入/質問フォーム
Enterprise-wide LicenseUSD4,850 ⇒換算¥504,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAxis Research Mind社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Axis Research Mind社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global Market Watch:
Global Hemodynamic Monitoring Devices sector is projected to reach US$1.3 billion by 2016. The North America accounts for nearly 32% (2015) of the global share while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 27.3% driving a market value of US$283 million by 2015. On a global scale, projections for Cardiac Output Monitoring Devices indicate more than 50% market share leaving the rest of the market to the Pulmonary Artery Catheters.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report ‘Hemodynamic Monitoring Devices – Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

· Emerging Market Trends

· Advancements in the Technological Space

· Market Demand of The Segments (By-Region)

· Key Growth Areas and Market Size

· Region-Wise Demand Factor

· Key Competitors Edge

· Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:

Hemodynamic Monitoring Devices – By Type

a. Cardiac Output Monitoring Devices (Minimally Invasive and Non-Invasive Devices)

b. Pulmonary Artery Catheters (PAC) (Invasive)

The period considered for the hemodynamic monitoring devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 132 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

【レポートの目次】

I. REPORT FOCUS

A. INTRODUCTION

CARDIOLOGY

KINDS OF CARDIAC CONDITIONS

A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION

TYPES OF CARDIAC ARREST

C. MYOCARDIUM

DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES

DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT

TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES

DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT

TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME

TOOLS DEPLOYED IN CARDIOLOGY

DIAGNOSTIC TESTS AND PROCEDURES

CONCLUSION

C. HEMODYNAMIC MONITORING

I. INVASIVE HEMODYNAMIC MONITORING

PURPOSES

OBJECTIVES

INDICATIONS

ADVANTAGES AND DISADVANTAGES OF HEMODYNAMIC MONITORING TEST

WHEN IT IS DONE?

THE PROCESS OF HEMODYNAMIC MONITORING

OTHER HEMODYNAMIC VARIABLES

INDICATIONS

RISK FACTORS/COMPLICATIONS

MARKET RESEARCH

KEY COMPANIES

II. CARDIAC OUTPUT MONITORING: AN INTEGRATIVE PERSPECTIVE

OVERVIEW OF CARDIAC OUTPUT MONITORING DEVICES

INVASIVE CARDIAC OUTPUT MONITORING

MINIMALLY INVASIVE CARDIAC OUTPUT MONITORING

PULSE PRESSURE ANALYSIS

DOPPLER CARDIAC OUTPUT MONITORING DEVICES

BIOIMPENDANCE AND BIOREACTANCE

CONCLUSION

D. HEMODYNAMIC MONITORING DEVICES – MARKET BRIEFING

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

II. MARKET ANALYSIS

HEMODYNAMIC MONITORING DEVICES – INDUSTRY SNAPSHOT

A. HEMODYNAMIC MONITORING DEVICES – SEGMENTATION

HEMODYNAMIC MONITORING DEVICES – GLOBAL

HEMODYNAMIC MONITORING DEVICES – BY GEOGRAPHY

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

HEMODYNAMIC MONITORING DEVICES – BY TYPE

HEMODYNAMIC MONITORING DEVICES – TYPE – BY GEOGRAPHY

CARDIAC OUTPUT MONITORING DEVICES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

PULMONARY ARTERY CATHETERS (PAC)

NORTH AMERICA

EUROPE

ASIA-PACIFIC

LATIN AMERICA

REST OF WORLD

B. GROWTH RATE ANALYSIS

GLOBAL HEMODYNAMIC MONITORING DEVICES – MARKET GROWTH RATES

GLOBAL HEMODYNAMIC MONITORING DEVICES – GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS

AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES

CARDIAC RHYTHM MANAGEMENT DEVICES

CRM IN EUROPE

CARDIAC DEFIBRILLATORS

RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES

THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES

THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS

INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET

THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES

CORONARY STENTS

EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET

MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS

COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)

GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE

DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING

NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)

GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES

ARTERIOTOMY CLOSURE DEVICES

EMBOLIC PROTECTION DEVICES (EPD)

INFERIOR VENA CAVA (IVC) FILTERS

CONCLUSION

PERIPHERAL GUIDEWIRES

AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES

SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW

MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE

DRIVERS IN THE MEDICAL IMPLANT INDUSTRY

SIZE AND WEIGHT

POWER EFFICIENCY

PERFORMANCE SPECIFICATIONS

RISK MITIGATION AND RELIABILITY

EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE

CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY

IMPACT OF CVD IN EUROPE

IMPACT ON NEW YORK STATE

ECONOMIC IMPACT OF CVD IN NYS

HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION

IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS

PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL

CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART’S NATURAL REPAIR SYSTEMS

GE HEALTHCARE’S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS

GE’S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.

CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE

INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)

TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS

INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS

STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)

VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING

VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING

STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION

GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL

MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES

B. BRAUN’S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD

MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING

RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH

A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN

ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY

SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.

FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK’S NEW EVIA HF-T PACEMAKER.

AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL

SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS

USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS

MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.

MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT

DRUG-ELUTING STENTS ARE SECURE

CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE’S USER SATISFACTION SURVEY

ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME

ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT

ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.

BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.

HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS

FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK

FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”

BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE

COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET

MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE

MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.

NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH

FIRST IMPLANT OF BOSTON SCIENTIFIC’S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA

STUDY REVEALS THAT BAYER HEALTHCARE’S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.

USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS

SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011

TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY

CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL

SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)

EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.

ZOLL NOMINATED TO GLOBE 100 AGAIN

USCOM ENTERS EUROPEAN MARKETS

POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS

USCOM SECURES STRONG PRESENCE IN US AND CANADA

CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES

COVIDIEN INTRODUCES NEW GLOBAL PACKAGING

STENTYS’S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.

SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT

CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD

USCOM EYES EASTERN EUROPEAN MARKET

VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART

INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES

INFECTIONS FROM IMPLANTED CARDIAC DEVICES

TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION

HEART TRANSPLANTS SUBSTITUTED BY A PUMP

DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)

REMOTE MONITORING OF HEART FAILURE PATIENTS

EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES

OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION

IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH

OVER-THE-COUNTER APPARATUS

BOSTON SCIENTIFICS’ IMPLANTABLE DEFIBRILLATOR

CARDIAC SCIENCE’S NEW CARDIAC TREATMENT

THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION

CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD

LOCAL MEDICARE’S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY

A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION

A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC

LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA

INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS

BEST AND LATEST SELF-TEACHING HEART SOUNDS

REPLACING VALVE WITHOUT CARDIAC SUPPORT

U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT

AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES

NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA

MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES

NORTH AMERICA

EUROPE

ASIA-PACIFIC

REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES – PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

RESEARCH FOCUS

ABOUT AXIS RESEARCH MIND

DISCLAIMER

FEEDBACK

I. REPORT FOCUS

1. FACTORS AFFECTING SELECTION OF CARDIAC OUTPUT MONITORING DEVICES

2. KEY COMPANIES LIST OF HEMODYNAMIC MONITORING TECHNIQUES

D. HEMODYNAMIC MONITORING DEVICES - MARKET BRIEFING

NORTH AMERICA

3. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR NORTH AMERICA - (2012-2018, IN USD$ MILLION)

4. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF NORTH AMERICA MARKET VALUE - (2015 - 2018)

EUROPE

5. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR EUROPE - (2012-2018, IN USD$ MILLION)

6. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF EUROPEAN MARKET VALUE - (2015 - 2018)

ASIA-PACIFIC

7. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)

8. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF ASIA-PACIFIC MARKET VALUE - (2015 - 2018)

LATIN AMERICA

9. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR LATIN AMERICA - (2012-2018, IN USD$ MILLION)

10. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF LATIN AMERICA MARKET VALUE - (2015 - 2018)

REST OF WORLD

11. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR REST OF WORLD- (2012-2018, IN USD$ MILLION)

12. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF REST OF WORLD MARKET VALUE - (2015 - 2018)

13. CARDIAC OUTPUT MONITORING DEVICES - PRODUCT BY BRANDS

II. MARKET ANALYSIS

14. GLOBAL HEMODYNAMIC MONITORING DEVICES - SEGMENTATION BY TYPE

HEMODYNAMIC MONITORING DEVICES - GLOBAL

15. HEMODYNAMIC MONITORING DEVICES MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)

16. HEMODYNAMIC MONITORING DEVICES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)

17. HEMODYNAMIC MONITORING DEVICES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)

HEMODYNAMIC MONITORING DEVICES - BY GEOGRAPHY

NORTH AMERICA

18. HEMODYNAMIC MONITORING DEVICES MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)

19. HEMODYNAMIC MONITORING DEVICES - % OF USA AND CANADA MARKET VALUE - (2015-2018)

EUROPE

20. HEMODYNAMIC MONITORING DEVICES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)

21. HEMODYNAMIC MONITORING DEVICES - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)

ASIA-PACIFIC

22. HEMODYNAMIC MONITORING DEVICES MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)

23. HEMODYNAMIC MONITORING DEVICES - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)

LATIN AMERICA

24. HEMODYNAMIC MONITORING DEVICES MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA -
(2012-2018, IN USD$ MILLION)

25. HEMODYNAMIC MONITORING DEVICES - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)

REST OF WORLD

26. HEMODYNAMIC MONITORING DEVICES MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)

27. HEMODYNAMIC MONITORING DEVICES - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)

HEMODYNAMIC MONITORING DEVICES – BY TYPE

28. HEMODYNAMIC MONITORING DEVICES MARKET - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)

29. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - % OF GLOBAL MARKET VALUE - (2015-2018)

HEMODYNAMIC MONITORING DEVICES - TYPE - BY GEOGRAPHY

CARDIAC OUTPUT MONITORING DEVICES

30. CARDIAC OUTPUT MONITORING DEVICES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)

31. CARDIAC OUTPUT MONITORING DEVICES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)

NORTH AMERICA

32. CARDIAC OUTPUT MONITORING DEVICES MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)

33. CARDIAC OUTPUT MONITORING DEVICES - % OF USA AND CANADA MARKET VALUE - (2015-2018)

EUROPE

34. CARDIAC OUTPUT MONITORING DEVICES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)

35. CARDIAC OUTPUT MONITORING DEVICES - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)

ASIA-PACIFIC

36. CARDIAC OUTPUT MONITORING DEVICES MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)

37. CARDIAC OUTPUT MONITORING DEVICES - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)

LATIN AMERICA

38. CARDIAC OUTPUT MONITORING DEVICES MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)

39. CARDIAC OUTPUT MONITORING DEVICES - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)

REST OF WORLD

40. CARDIAC OUTPUT MONITORING DEVICES MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)

41. CARDIAC OUTPUT MONITORING DEVICES - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)

PULMONARY ARTERY CATHETERS (PAC)

42. PULMONARY ARTERY CATHETERS (PAC) MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)

43. PULMONARY ARTERY CATHETERS (PAC) - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)

NORTH AMERICA

44. PULMONARY ARTERY CATHETERS (PAC) MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)

45. PULMONARY ARTERY CATHETERS (PAC) - % OF USA AND CANADA MARKET VALUE - (2015-2018)

EUROPE

46. PULMONARY ARTERY CATHETERS (PAC) MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)

47. PULMONARY ARTERY CATHETERS (PAC) - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)

ASIA-PACIFIC

48. PULMONARY ARTERY CATHETERS (PAC) MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)

49. PULMONARY ARTERY CATHETERS (PAC) - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)

LATIN AMERICA

50. PULMONARY ARTERY CATHETERS (PAC) MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)

51. PULMONARY ARTERY CATHETERS (PAC) - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)

REST OF WORLD

52. PULMONARY ARTERY CATHETERS (PAC) MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)

53. PULMONARY ARTERY CATHETERS (PAC) - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)

B. GROWTH RATE ANALYSIS

GLOBAL HEMODYNAMIC MONITORING DEVICES - MARKET GROWTH RATES

54. HEMODYNAMIC MONITORING DEVICES MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2012-2018)

GLOBAL HEMODYNAMIC MONITORING DEVICES - GROWTH RATES

55. HEMODYNAMIC MONITORING DEVICES - % GROWTH RATE FORECASTS FOR CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS (PAC) - (2012-2018)

C. INVESTMENT FOCUS

56. HEMODYNAMIC MONITORING DEVICES - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

57. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW

58. INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)

59. INTRAVENOUS DIAGNOSTICS – BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)

60. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)

61. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)

62. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)

63. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES

64. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES

65. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES

66. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014

67. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013

68. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE

69. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

70. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME

71. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014

72. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME

73. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)

74. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)

75. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)

76. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)

77. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)

78. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)

79. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)

80. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)

81. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)

82. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)

83. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)

84. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)

85. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)

86. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

87. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)

88. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD

89. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

90. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)

91. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)

92. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)

93. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)

94. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)

95. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)

96. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)

97. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)

98. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

99. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)

100. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

101. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)

102. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)

103. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

104. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)

105. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)

106. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)

107. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)

108. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)

109. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)

110. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)

111. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)

112. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)

113. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

114. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)

115. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)

116. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)

117. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)

118. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)

119. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)

120. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)

121. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)

122. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)

123. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)

124. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)

125. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)

126. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)

127. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)

128. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)

129. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)

130. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)

131. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)

132. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥’ YEN)

【レポートのキーワード】

血行動態モニタリング装置、心拍出量モニタリング装置、肺動脈カテーテル、心拍出量モニタリング、医療機器

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の血行動態モニタリング装置市場:心拍出量モニタリング装置、肺動脈カテーテル]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆